About the Author

Dr Anupama

BDS (Bachelor of Dental Surgery), MIDA

Anupama has over thirty-one years of experience, which encompasses a blend of professional practice as a Dental Surgeon, academic roles in teaching and research, administration, and technical writing.
She has co-authored eight textbooks in the subject areas of biotechnology and environmental sciences, and has also published research papers. Some of her key publications are as follows –

Introduction to Biotechnology (ISBN: 978-81-7700-003-0)
Biotechnology and Environmental Chemistry (ISBN: 978-81-7700-040-3)
A Basic Course in Environmental Studies (ISBN: 978-81-7700-203-4)
Energy, Environment, Ethics & Society (ISBN: 978-81-7700-008-5)

You can connect with Anupama at editor@druganddeviceworld.com

Dr Phalguni Deswal

MBBS (Bachelor of Medicine, Bachelor of Surgery), MSc Diabetes, MSc Healthcare Management

Phalguni has over two years of experience in medical content writing. She has also written for multiple sites, including Pharmaceutical Technology, Medical Device Network, and Clinical Trials Arena, covering daily news and writing long form features on the big trends in the pharmaceutical and medical device sectors. She is also a registered physician in India.

She also does independent research and has been published in SCOPUS journal. You can check out her latest research below:

She has written a review on Article 6 of the Paris Agreement, with a focus on the mechanisms, progress, and persistent challenges.
A co-authored a research paper titled “Sustainability: Greenhouse Gas Protocol and Global GHG Emissions’ Status and Trends” with a subject matter expert, Dr Surinder Deswal, professor of environmental engineering at the National Institute of Technology.
The research titled “Machine Learning in Healthcare Sector: Algorithms, Applications, Challenges and Prospects” which was published in the January 2025 issue of the Journal of Technology.
She also co-authored a review article on noise pollution in hospitals.

You can connect with Phalguni on LinkedIn or email her at phalgunideswal@gmail.com

Latest posts

From gut resets to microbiome rejuvenation: DDW 2026 highlights transformative approaches to digestive health

An endoscopic procedure that maintains weight loss after stopping GLP-1 drugs, the double hit of stress and late-night eating on gut health, rising rectal cancer deaths in millennials, and youthful microbiome transplants that prevent liver cancer.

May 5, 2026
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML

The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.

January 6, 2026
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors

Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.

May 5, 2026
Beyond the Snapshot: Continuous physiologic monitoring in clinical trials

Vivalink’s CEO discusses how continuous physiologic monitoring is transitioning from a niche tool for early-stage feasibility studies to a core component of late-stage drug development.

April 16, 2026
Patients open to non-GLP-1 drugs after education, survey finds

A survey finds that while most patients remain unfamiliar with obesity treatments beyond GLP-1s, comprehensive education about alternatives significantly shifts attitudes toward personalized care.

April 9, 2026
ACC26: Amgen’s Repatha cuts first major CV event risk by 31%

New data show Repatha significantly reduces first heart attacks and strokes in high-risk patients without known significant plaque buildup.

April 9, 2026